EQL's key product methenamine hippurate has now gained marketing approval by the Health Authorities in Germany, where it is to be provided to patients by EQL's license partner Dr Pfleger under the EQL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback